Immuneering Corporation
NASDAQ:IMRX
2.28 (USD) • At close September 18, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
| Operating Activities: | |||||
| Net Income
| -53.472 | -50.514 | -33.536 | -17.04 | -7.709 |
| Depreciation & Amortization
| 0.352 | 0.797 | 0.159 | 0.079 | 0.018 |
| Deferred Income Tax
| 0 | 0 | -0.307 | -0.35 | 0.739 |
| Stock Based Compensation
| 5.727 | 4.064 | 1.803 | 1.087 | 0.597 |
| Change In Working Capital
| -0.975 | 1.717 | 0.9 | 1.253 | 0.437 |
| Accounts Receivables
| 0.012 | 0.234 | 0.28 | -0.29 | 0.614 |
| Inventory
| 0 | 0 | 0 | 0 | 0.018 |
| Accounts Payables
| -1.107 | 1.76 | -0.13 | 1.186 | 0.27 |
| Other Working Capital
| 0.12 | -0.277 | 0.751 | 0.358 | -0.465 |
| Other Non Cash Items
| -0.602 | -0.166 | 0.13 | 0.35 | 1.476 |
| Operating Cash Flow
| -48.969 | -44.101 | -30.851 | -14.621 | -4.442 |
| Investing Activities: | |||||
| Investments In Property Plant And Equipment
| -0.343 | -0.742 | -0.061 | -0.053 | -0.021 |
| Acquisitions Net
| -7.296 | -41.831 | 0.07 | 0 | 0 |
| Purchases Of Investments
| -44.661 | -50.105 | -75.626 | 0 | 0 |
| Sales Maturities Of Investments
| 52.3 | 92.678 | 75.616 | 0 | 0 |
| Other Investing Activites
| 7.296 | 41.831 | -75.616 | 0 | 0 |
| Investing Cash Flow
| 7.296 | 41.831 | -75.616 | -0.053 | -0.021 |
| Financing Activities: | |||||
| Debt Repayment
| 0 | 0 | 0 | 0 | -3.825 |
| Common Stock Issued
| 28.2 | 0.019 | 120.319 | 37.982 | 17.228 |
| Common Stock Repurchased
| 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| 0.241 | 0.019 | 23.946 | 37.982 | -0.056 |
| Financing Cash Flow
| 28.441 | 0.019 | 144.265 | 37.982 | 17.172 |
| Other Information: | |||||
| Effect Of Forex Changes On Cash
| 48.968 | 0 | 0 | 0 | 0 |
| Net Change In Cash
| -13.231 | -2.251 | 37.798 | 23.308 | 12.708 |
| Cash At End Of Period
| 59.406 | 72.637 | 74.888 | 37.09 | 13.782 |